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Regular Article
HEMATOPOIESIS AND STEM CELLS
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Key Points
• Notch1/DII4-mediated signals
are normally suppressed by
LRF, preventing HSCs from
premature T-cell differentiation
in the bone marrow.
• Erythroblastic islands may
have the capacity to regulate
the fate and function of HSCs.
Hematopoietic stem cells (HSCs) are the most primitive cells in the hematopoietic
system and are under tight regulation for self-renewal and differentiation. Notch signals
are essential for the emergence of definitive hematopoiesis in mouse embryos and
are critical regulators of lymphoid lineage fate determination. However, it remains
unclear how Notch regulates the balance between HSC self-renewal and differentia-
tion in the adult bone marrow (BM). Here we report a novel mechanism that pre-
vents HSCs from undergoing premature lymphoid differentiation in BM. Using a series
of in vivo mouse models and functional HSC assays, we show that leukemia/
lymphoma related factor (LRF) is necessary for HSC maintenance by functioning
as an erythroid-specific repressor of Delta-like 4 (Dll4) expression. Lrf deletion in
erythroblasts promoted up-regulation of Dll4 in erythroblasts, sensitizing HSCs to T-cell
instructive signals in the BM. Our study reveals novel cross-talk between HSCs and
erythroblasts, and sheds a new light on the regulatory mechanisms regulating the balance between HSC self-renewal and
differentiation. (Blood. 2013;121(6):918-929)
Introduction
For life-long hematopoiesis, most immature hematopoietic stem
cells (HSCs), so-called long-term HSCs (LT-HSCs), remain dor-
mant, but in response to hematopoietic stress, they actively cycle to
generate multi-lineage blood cells without depleting the HSC
pool.1 These fate decisions are governed by intrinsic and extrinsic
mechanisms. Relevant to extrinsic regulation, adult HSCs reside in
a specialized microenvironment within the bone marrow (BM), the
“niche,” which is composed of multiple types of supporting cells
that express membrane-bound and secreted factors.2,3 Osteoblasts,
endothelial cells, perivascular cells, mesenchymal stem cells, and
glial cells have been proposed as components of the BM microenvi-
ronment.3 These studies reveal how both self-renewal and quies-
cence of adult HSCs are maintained; however, how the balance
between self-renewal and differentiation is regulated in the niche
remains largely unknown.
The highly conserved Notch signaling pathway regulates many
cell-fate decisions and homeostasis in various organs.4 In humans
its dysregulation is associated with many types of cancer and
inherited congenital anomalies.4 There are 4 mammalian homologs
of the Notch receptor (Notch 1-4) and 5 ligands: Delta-like-1, 3 and
4, which belong to the Delta ligand family, and Jagged-1 and 2,
which belong to the Serrate family.5 After ligand engagement, the
intracellular domain of the Notch receptor (ICN) undergoes
multiple proteolytic cleavages and translocates to the nucleus,
where it binds the recombination signal-binding protein 1 for j
(RBP-j, also known as CSL/CBF1) and mastermind-like coactivators
(MAML1-3), and activates downstream targets, such as hairy and
enhancer of split homologue-1 (Hes-1).5 Notch is indispensable for the
emergence of embryonic hematopoiesis6; however, its role in adult HSC
function is controversial. In addition, it is not completely understood at
which HSC/progenitor stages Notch receptors are expressed and which
Notch ligands are expressed in the BM microenvironment.
LRF (for leukemia/lymphoma related factor), also known as
Pokemon, ZBTB7a, FBI-1, and OCZF, is a POZ and Kru¨ppel
(POK)–type transcription factor with multiple functions in hemato-
poietic development, oncogenesis, and humoral immunity.7 In
mice, Lrf (encoded by the Zbtb7a gene) inactivation in adult HSCs
(Zbtb7aFlox/FloxMx1-Cre) promotes development of CD4/8 double-
positive (DP) T cells in the BM at the expense of B-cell
development.8 Treatment of Lrf-deleted mice with  secretase
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inhibitors, which block Notch signaling, rescues aberrant lymphoid
development, suggesting that Lrf antagonizes the Notch pathway at
the HSC/progenitor level.8 Furthermore, despite its critical role in
the B versus T-lymphoid lineage fate determination, Lrf is dispens-
able for maintenance of “committed” BM B cells, as early B-cell
development in the BM is grossly normal when the Lrf gene is
inactivated at the pro-B cell stage.9
In this study, we asked how HSC self-renewal and lymphoid
differentiation is balanced in the context of Notch signaling in adult
BM. We show that Notch1/Dll4-mediated T-cell instructive signals
to LT-HSCs are suppressed by Lrf expression in the BM
microenvironment.
Methods
Mice
Lrf conventional (Zbtb7a/), Lrf conditional (Zbtb7aFlox/Flox), Notch1
conditional knockout and erythroid-specific Cre mice (ErGFPCre) are
described elsewhere.8,10-12 All Mx1-Cre mice were injected with polyinosinic-
polycytidylic acid (pIpC; Sigma-Aldrich) 2 or 3 times at 3-day intervals at
4 to 8 weeks of age, unless otherwise indicated. For functional analysis of
LT-HSCs, C57BL/6 mice (10-12 weeks old) were obtained from JAX.
B6.SJL-PtprcaPepcb/BoyJ mice served as recipients for BM transplant. All
mice were housed at the City of Hope (COH) Animal Resources Center or
at Animal Resource Children’s Hospital Boston (ARCH). All animal
experiments were approved by the Institutional Animal Care and Use
Committees, according to national, state, and institutional guidelines.
Statistical analysis
P values were determined by Mann-Whitney test using Prism Version 5.0d
software (GraphPad).
Results
Lrf knockout mice show significantly reduced numbers of
LT-HSCs and Flt3 lymphoid progenitors
To determine at which HSC/progenitor stage Lrf counteracts Notch
signaling, we positively selected c-Kit cells and then performed
multi-color fluorescence-activated cell sorting (FACS) analysis
with antibodies for cell surface markers, including SLAM family
proteins, Flt3 and Vcam-1.13,14 LT-HSCs and CLPs were defined as
LinIL7RSca1c-KitFlt3CD150CD48Vcam-1dim and
LinIL7RFlt3CD48Vcam-1-15, respectively. In Lrf knockout
mice, the Flt3-positive population was barely detectable within the
LSK fraction (Figure 1A), and LinIL7RSca1c-Kit cells,
which we previously proposed to be CLPs (Figure 1A asterisk),8
were Flt3-negative. Instead, early T-cell precursors, which showed
high CD25 expression (not shown), accumulated within the LSK
fraction (Figure 1A arrowhead, bottom row, second from right).
Furthermore, both the proportion and absolute number of LT-HSCs
were significantly reduced in Zbtb7aFlox/FloxMx1-Cre mice relative
to control (Figure 1B). CD34 is a reliable marker of primitive
hematopoietic cells,15 few CD34 LT-HSCs were seen in
Zbtb7aFlox/FloxMx1-Cre mice (Figure 1C). Loss of LT-HSCs in Lrf
knockout mice was confirmed by Hoechst 33342–based side
population (SP) analysis (Figure 1D). HSC compartments in fetal
liver (FL) of Lrf knockout (Zbtb7a/) embryos were also exam-
ined at 13.5 days postcoitum (dpc). As in adult BM, FL-LT-HSCs
numbers were significantly reduced (Figure 1E) with a concomitant
increase in the number of T-cell precursors16 at the expense of
B-cell development (Figure 1F-G).8 Taken together, these observa-
tions indicate that Lrf deficiency significantly reduces the number
of LT-HSCs and lymphoid progenitors and is accompanied by
enhanced production of T-cell precursors in adults and embryos.
Lrf-deficient LT-HSCs lose their stem cell signature
Next we performed gene expression microarray analysis of FACS-
sorted LT-HSCs to assess the effect of Lrf loss on the LT-HSC
transcriptome. Nine days after injection of adult mice with pIpC to
activate Cre, total RNAs were isolated from double-sorted LT-HSCs
from Zbtb7aFlox/Mx1-Cre and Zbtb7aFlox/FloxMx1-Cre mice and
processed for microarray analysis (supplemental Figure 1A, avail-
able on the Blood Web site; see the Supplemental Materials link at
the top of the online article). This time point was chosen because:
(1) the number of LT-HSCs was temporally increased but equiva-
lent between control and Lrf-deficient mice and (2) to minimize
potential effects of pIpC on the HSC cell cycle.17 PIpC-treated
Zbtb7aFlox/Mx1-Cre mice served as controls to normalize for
potential effects of Cre recombinase expression and pIpC adminis-
tration. Gene set enrichment analysis (GSEA) was performed using
publicly available gene sets representing expression signatures
seen in HSC/progenitors.18,19 Although there were no differences in
HSC number or expression patterns of HSC markers between control
(Zbtb7aFlox/Mx1-Cre pIpC) and Lrf knockout (Zbtb7aFlox/FloxMx1-
Cre pIpC) mice at the time of sample collection, overall gene
expression signatures were significantly changed. In Lrf-deficient
LT-HSCs, stem cell signatures were substantially lost, whereas
genes related to T-cell receptor signaling pathways were enriched
(supplemental Figure 1B). Database for annotation, visualization,
and integrated discovery (DAVID) analysis revealed 112 probe sets
up or down-regulated more than 1.5-fold in Lrf-deficient LT-HSCs
relative to controls (supplemental Tables 1 and 2). The most
significant and over-represented biologic annotations in those cells
were T-cell related (supplemental Figure 1C). Microarray data are
available at GEO under accession number GSE41839.
HSC function under stress conditions is impaired in Lrf
knockout mice
Cycling HSCs are sensitive to treatment with 5-fluoro-uracil
(5-FU), an S phase-specific cytotoxic chemotherapeutic agent.17,20
To examine LT-HSC self-renewal capacity under stress conditions,
Zbtb7aFlox/FloxMx1-Cre mice were challenged with 5-FU 9 days
after the first of 2 (days 1 and 3) pIpC injections, and absolute
numbers of LT-HSCs were examined over time. As previously
reported, pIpC treatment induced a temporary increase in total
LT-HSC number, regardless of genotype.17 These numbers dropped
dramatically 1 day after 5-FU treatment (Figure 2A). Although
LT-HSC numbers in control mice recovered to pretreatment levels
3 weeks after 5-FU treatment, their levels in knockout mice
remained low. Of note, DP T cells, which were not seen before
5-FU treatment in either genotype, developed in the BM of Lrf
knockout mice 3 weeks after 5-FU treatment (not shown), suggest-
ing that 5-FU–resistant dormant HSCs differentiate toward the
T-cell lineage rather than self-renewing in response to the myeloab-
lative stress (Figure 2B).
We next performed in vivo BM transplantation (BMT)/
competitive repopulation experiments. To do so, control or Lrf-
deficient LT-HSCs were transferred to lethally irradiated recipient
mice and reconstitution of donor-derived cells (CD45.2) in
lymphoid and myeloid lineage cells was determined by peripheral
blood (PB) FACS analysis. Lrf inactivation was induced by 2 pIpC
injections at 3-day intervals. Then, 50 LT-HSCs (CD45.2), which
had been FACS-sorted twice to ensure purity, together with support
BM mononuclear cells (CD45.1) were transplanted per mouse
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(Figure 2C). As anticipated,8 we observed significantly fewer
donor-derived B-cells in recipients transplanted with Lrf-deficient
LT-HSCs. Moreover, despite accumulation of donor-derived DP
T cells in the BM (not shown), donor-derived PB T cells were also
Figure 1. Lrf knockout mice show significantly reduced numbers of LT-HSCs and Flt3 lymphoid progenitors. (A) Representative HSC/progenitor FACS profiles of
control (Zbtb7aFlox/FloxMx1-Cre) and hematopoietic-specific Lrf knockout mice (Zbtb7aFlox/FloxMx1-Cre). c-Kit–positive cells were purified from total BM cells using c-Kit
microbeads and MACS LS columns and stained for surface markers. Arrowhead (bottom row, second from right) indicates CD48high T-cell progenitors within the LSK
CD150Flt3 population. Aberrant Sca1high T-cell progenitors within the LinFlt3Il7R fraction are depicted with an asterisk (second row from bottom, left). LT-HSC: long-term
hematopoietic stem cell; CLP: common lymphoid progenitor. (B) Dot graphs of absolute counts of LT-HSCs [LSK (LinSca1c-Kit) Il7RFlt3CD150CD48VCAM1dim] and CLPs
(LinIl7RFlt3CD150CD48VCAM1) per 2 legs (2 tibias and 2 femurs). Horizontal black bars: average value; error bars: standard deviation. (C) Proportions of CD34-negative
LT-HSCs within the LSK CD150Flt3 population. Horizontal black bars: average value; error bars: standard deviation. (D) Representative FACS profiles of side population analysis in BM
cells from control and Lrf knockout mice. (E)Absolute numbers of LT-HSCs in 13.5 dpc fetal liver (FL) from WT(/), Lrf heterozygous (/) and Lrf knockout (/) mice. Horizontal black
bars: average value; error bars: standard deviation. (F) Representative FACS profiles for FLT-cell precursors. (G) Dot graphs show proportions (left) and absolute counts (right) of FLT-cell
precursors (TER119Gr1c-KitPIRIL7R) in 13.5 dpc FL cells. Horizontal black bars: average value; error bars: standard deviation.
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reduced in recipients transplanted with Lrf-deficient LT-HSCs
(Figure 2D). In contrast, reconstitution of myeloid lineage cells
was largely unaffected in either genotype. Moreover, Lrf-
deficient LT-HSCs produced myeloid and erythroid lineage cells
for a long period after Lrf deletion. We followed hematopoiesis in
Zbtb7aFlox/FloxMx1-Cre mice for up to 18 months after the last pIpC
injection (Figure 2E).Although LT-HSC numbers remained low (supple-
mental Figure 1D), Lrf-deficient LT-HSCs maintained long-term
hematopoiesis. DPT cells were evident in the BM of Lrf knockout mice,
with a concomitant block of B-cell development. Expansion of imma-
ture erythroblasts, which underlies the anemia phenotype seen in Lrf
knockout mice,21 and normal development of myeloid lineage cells was
observed in the spleen (Figure 2E). Quantitative RT-PCR (qRT-PCR)
revealed little or no Lrf mRNA in multiple lineage cells, confirming
Lrf-deficient hematopoiesis (not shown).
CD34 LT-HSCs expressing high levels of Notch are sensitive
to Lrf inactivation
We examined surface Notch expression in HSC/progenitor compart-
ments with various Notch monoclonal antibodies22 using HSCs/
progenitors from Notch1 knockout mice (Notch1Flox/FloxMx1-Cre)
as negative controls. For Notch1 FACS, signal intensities of
Notch1-deficient cells and those of the FMO control completely
overlapped, indicating antibody specificity (Figure 3A). Notch1
protein was expressed at lower levels relative to lymphoid-
restricted progenitors in the CD34-negative LT-HSC fraction
(LSK CD150CD48Flt3IL7RCD34: CD34 LT-HSC),
which is the most primitive fraction, and Notch1 expression
increased as cells differentiated toward lymphoid-restricted progeni-
tors (Figure 3A). By contrast, Notch2 was highly expressed in
Figure 2. In vivo function of Lrf in HSCs. (A) Lrf knockout mice were challenged with 5-FU 9 days after the first pIpC injection and LT-HSC recovery was examined at
indicated times. Graph shows absolute numbers of LT-HSCs after 5-FU treatment over time. Horizontal black bars: average value; error bars: standard deviation. (B) In
Zbtb7aFlox/FloxMx1-Cre mice, 5-FU–resistant dormant HSCs differentiate toward the T-cell lineage rather than self-renewing in response to the myeloablative stress.
(C) Schematic representation of bone marrow transplantation (BMT). Fifty double-sorted LT-HSCs were transplanted into lethally irradiated CD45.1 recipient mice. (D) Shown
are time-course follow-up of recipients’ PB counts [myeloid (Gr1CD11b), B (B220), and T cells (CD4 or CD8)]. Error bars: standard deviation. (E) BM hematopoiesis was
followed up to 18 months after the last pIpC injection. Representative FACS profiles of hematopoietic development in BM and spleen analyzed 1 year after the last pIpC
injection in control (Zbtb7aFlox/FloxMx1-Cre) and Lrf knockout (Zbtb7aFlox/FloxMx1-Cre) mice. BM DP T-cell development, B-cell differentiation block, normal myeloid
development, and an anemia phenotype in spleen21 were evident in Lrf knockout mice.
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LT-HSCs and its expression was reduced in CLPs. Notch3 and
Notch4 were not detected in any normal HSC/progenitor compart-
ment (not shown), but Notch3 was up-regulated in the Lrf-deficient
progenitor fraction, which presumably consists of T-cell precursors
(supplemental Figure 2).
We next examined Notch expression levels in Lrf-deficient
CD34 LT-HSCs 1 month after the last pIpC injection (Figure 3B).
CD34 LT-HSCs expressing high levels of Notch were absent,
whereas those expressing low levels remained in the BM (Figure
3B). Mean fluorescence intensitie (MFI) of surface Notch protein
in Lrf-deficient CD34 LT-HSCs were significantly lower com-
pared with controls (Figure 3B-C). Thus, CD34 LT-HSCs express-
ing high levels of Notch proteins are particularly sensitive to Lrf
inactivation and differentiate into T cells in the BM.
Notch1 loss rescues aberrant lymphoid lineage fate and HSC
defects in Lrf knockout mice
Treatment of Zbtb7aFlox/FloxMx1-Cre mice with -secretase inhibi-
tors rescues normal lymphoid development,8 and Notch1 condi-
tional knockout mice exhibit phenotypes reciprocal to those of Lrf
knockout mice.10 Because CD34 LT-HSCs expressing low levels
of Notch were largely unaffected by Lrf inactivation, we asked
whether loss of Notch receptor(s) in Lrf-deficient LT-HSCs would
normalize BM hematopoiesis. To do so, we generated Lrf/Notch1
double-knockout mice (Zbtb7aFlox/FloxNotch1Flox/FloxMx1-Cre) and
analyzed BM hemato/lymphoid development. As expected, DP
T cells, which were seen in Lrf knockout mice, were completely
absent and the proportions of BM B cells were grossly normal in
Lrf/Notch1 double-knockout mice (Figure 4A-B), whereas the
anemia phenotype persisted (not shown). Furthermore, absolute
numbers of LT-HSCs in Lrf/Notch1 double knockout mice were
significantly greater than those seen in Lrf knockout mice (Figure
4C). To determine whether Notch1 deficiency enhances self-
renewal of Lrf-deficient HSCs after 5-FU stress, double-knockout
mice were treated with 5-FU as described (Figure 2A), and LT-HSC
numbers were determined 3 weeks later. LT-HSC numbers in
double-knockout mice recovered to pretreatment levels and were
equivalent to control and Notch1 single-knockout mice (Figure
4D). We next assessed hematopoietic reconstitution capacity of
mutant mice in vivo by monitoring survival after sequential 5-FU
injection.20 Control, Lrf knockout, Notch1 knockout and Lrf/
Notch1 double-knockout mice were injected with pIpC twice, and
5-FU administered 9 days after the first injection, followed by
weekly 5-FU treatment. Lrf knockout mice died significantly
earlier than did control mice; however, Lrf/Notch1 double-
knockout mice survived as long as controls, suggesting that Notch1
loss restored the number of functional HSCs (Figure 4E). Unexpect-
edly, lack of Notch1 protected against sequential 5-FU treatment,
although mechanisms underlying this observation remain unknown.
Lrf represses Dll4 expression in erythroblasts
Our observations suggested that CD34 LT-HSCs expressing high
levels of Notch (Figure 3B) are hypersensitive to Notch signaling
caused by Lrf deficiency and that the signal is transmitted mainly
through Notch1 in the most primitive LT-HSCs (Figure 4).
Although microarray analysis (supplemental Figure 1A) had re-
vealed that expression of Notch receptors and ligands was un-
changed at the LT-HSC level, the Notch target Hes1 was up-
regulated in Lrf knockout cells (supplemental Table 1), a finding
confirmed by qRT-PCR of FACS-sorted LT-HSCs harvested at day
9 after the first pIpC injection (supplemental Figure 3A). These
data suggest Lrf does not directly regulate transcription of Notch
mRNA but rather that Notch transcriptional activity or Notch
receptor/ligand efficiency could be modulated. Coimmunoprecipi-
tation (Co-IP) analysis revealed no direct interaction between Lrf
and ICN1 or RBP-j, whereas ICN1 and RBP-j interacted as
expected (supplemental Figure 3B). We also asked whether Lrf
directly down-regulated transcription of Notch targets. To do so,
we used luciferase reporter assays with constructs containing either
artificial RBP-j/CSL binding sites (4xCSL-Luc) or the mouse
Figure 3. CD34 LT-HSCs expressing high levels of Notch are sensitive to Lrf inactivation. (A) Histograms show mean fluorescence intensity (MFI) for Notch1 and
Notch2 in indicated HSC/progenitor compartments. Signal levels in Notch1-deficient LT-HSCs (N1 KO: Notch1Flox/FloxMx1-cre) and fluorescence minus one (FMO) controls
are also shown. CLP: LinIL7RFlt3CD48; LMPP: LinIL7RSca1c-KitFlt3CD150CD48. (B) CD34 LT-HSCs expressing high levels of Notch are lost after
Lrf inactivation. Representative FACS profiles for Notch1 and Notch2 in control (Zbtb7aFlox/FloxMx1-Cre) and Lrf knockout (Zbtb7aFlox/FloxMx1-Cre) mice. All mice were
injected with pIpC 3 times, and Notch expression levels within the CD34 LT-HSC population analyzed 1 month after the last injection. Data for Notch1 KO, FMO, and control
are same as those shown in panel A. (C) Graph shows MFI of Notch staining in control (black) and Lrf-deficient (red) CD34 LT-HSCs 1 month after the last injection. Error bars:
standard deviation.
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Hes1 promoter (mHes1-Luc). Although ICN1 efficiently activated
both reporters, no transactivation/repression was seen in the
presence of Lrf overexpression (supplemental Figure 3C).
We next asked whether Lrf regulates Notch ligand expression or
receptor/ligand efficiency. The fact that Dll4 is indispensable for
T-cell development23 and is a nonredundant Notch 1 ligand in
thymus24 suggests that Dll4 might be a Notch ligand in the BM.
Immunohistochemical (IHC) analysis revealed that Dll4 is ex-
pressed on mature vessel endothelium and at lower levels on
immature endothelium, and that erythroid, lymphoid, myeloid, and
megakaryocyte colonies were Dll4-negative (Figure 5A, supplemen-
tal Figure 4). In spleen, Dll4 was seen on arteriolar endothelium of
the white pulp and the smaller blood vessels of the red pulp,
consistent with a previous report using Dll4-LacZ reporter mice.25
Strikingly, clusters of Dll4-positive cells were evident in the BM of
both Lrf knockout and Lrf/Notch1 double-knockout mice, indicat-
ing that Lrf deficiency up-regulates Dll4 independent of Notch1
(Figure 5A). FACS analysis further indicated that Dll4 up-
regulation was limited to erythroblasts at late stages of differentia-
tion. Specificities of the anti-Dll1 and -Dll4 antibodies were
confirmed using a series of OP9 stromal cell lines (supplemental
Figure 5A). Ter119CD71 cells, which consist primarily of
basophilic and polychromatophilic-erythroblasts, expressed Dll4 at
high levels, but early erythroid precursors (eg, colony forming unit
erythroid [CFU-E]) and terminally differentiated reticulocytes/
erythrocytes (Ter119CD71FSClow) did not (Figure 5B). Dll4 was
not expressed in either Lrf-deficient HSCs/progenitors or non-
erythroid cells (Figure 5B-C). Dll4 up-regulation was not because
of stress erythropoiesis seen in Zbtb7aFlox/FloxMx1 Cre mice,21 as
erythroblasts from phenylhydrazine (PHZ)–treated mice, a model
of stress hematopoiesis, did not express Dll4 (supplemental Figure
5B). Of note, Dll1 was not expressed in BM erythroblasts
regardless of genotype (supplemental Figure 5C). Dll4 up-
regulation in Lrf-deficient erythroblasts occurred at the transcrip-
tional level: Dll4 mRNA levels were 80- to 200-fold greater than
those seen in PHZ-treated WT mice (Figure 5D). Taken together,
Lrf-deficient erythroblasts express Dll4 at high levels, providing
T-cell instructive signals to the LT-HSCs in the BM. In agreement with
these findings, we occasionally observed competitor-derived (CD45.1)
DP T cells in the BM after BMT. BM mononuclear cells from
Figure 4. Notch1 loss rescued aberrant lymphoid fate determination and HSC defects in Lrf knockout mice. (A) Representative FACS profiles of BM B-cell
compartments in control, Lrf knockout (Zbtb7aFlox/FloxMx1-Cre), Notch1 knockout (Notch1Flox/FloxMx1-Cre), and Lrf/Notch1 double-knockout (Zbtb7aFlox/FloxNotch1Flox/Flox
Mx1-Cre) mice 1 month after the last pIpC injection. (B) Proportions of DP T (top) and pre-B cell compartments (bottom) in BM. Horizontal black bars: average value; error
bars: standard deviation. (C) Numbers of LT-HSCs recovered in Lrf knockout mice on Notch1 loss. Dot graph shows absolute numbers of LT-HSCs per 2 legs in indicated mice
1 month after the last pIpC injection. Horizontal black bars: average value; error bars: standard deviation. (D) LT-HSCs numbers recover normally after 5-FU challenge in
Lrf/Notch1 double-knockout mice. Dot graph shows absolute numbers of LT-HSCs per 2 legs in indicated mice 3 weeks after 5-FU treatment. Horizontal black bars: average
value; error bars: standard deviation. (E) Survival curves after sequential 5-FU treatment. 5-FU (100 mg/kg) was administered weekly. Survival rates in each group were
analyzed and P value calculated using a log-rank Mantel-Cox test.
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Zbtb7aFlox/FloxMx1 Cre and competitor (CD45.1) were mixed at 1:1
ratio and transferred to lethally irradiated recipient mice (CD45.1).
Four weeks after BMT, Lrf inactivation was induced with 3 pIpC
injections and BM T cells analyzed 1 month after the last pIpC injection.
Competitor-derived DP T cells were evident in recipients’ BM (supple-
mental Figure 5D), suggesting that Lrf-deficient erythroblasts provided
Dll4-mediated Notch signals to competitor-derived HSCs.
To assess Dll4 loss-of-function, we injected Lrf knockout mice
with a blocking anti-Dll4 antibody (5 mg/kg)26 twice a week for
3 weeks (Figure 6A). Dll4 blockade almost completely rescued
aberrant lymphoid development in Lrf knockout mice (Figure 6B),
whereas injection of blocking anti-Dll1 antibody did not (not
shown). B-cell numbers were significantly increased and DP T cells
were barely detected in the BM of anti-Dll4–treated Lrf knockout
mice (Figure 6C). Furthermore, the numbers of LT-HSCs and Flt3
lymphoid progenitors were substantially rescued in Lrf knockout
mice after anti-Dll4 treatment (Figure 6D, supplemental Figure
6A). Of note, the anemia phenotype seen in Lrf knockout mice21
was not rescued by Dll4 blockade (supplemental Figure 6B),
suggesting that it is Dll4-independent.
Figure 5. Lrf represses expression of Dll4 protein and mRNA in an erythroblast-specific manner. (A) Immunohistochemstry (IHC) of Dll4 in paraffin-embedded BM
sections from indicated mice. Magnification: 200 (top row) and 600 (bottom row). Dll4 expression was evident only in mature endothelium of control mice (top, left; black
arrowheads), whereas clusters of Dll4-positive cells (red arrowheads) were observed in Lrf knockout and Lrf/Notch1 double-knockout mice. (B) Dll4 expression levels during
erythroid differentiation were examined by FACS in control (gray) and Lrf knockout mice (black) 1 month after pIpC injections. Representative FACS histograms of cell surface
Dll4 at each differentiation stage are shown. MkP (megakaryocyte progenitor); PreMegE (pre-megakaryocyte–erythrocyte progenitor); CFU-E: colony-forming units-erythroid
and FSC (forward scatter: cell size). (C) Dll4 expression levels in myelo/lymphoid lineage cells. PreGM: pre-granulocyte macrophage progenitor and GMP: granulocyte
macrophage progenitor. (D) Dll4 mRNA levels were determined by qRT-PCR in FACS-sorted BM erythroid and myeloid cells from control, PHZ-treated control, and Lrf
knockout (Zbtb7aFlox/FloxMx1-Cre, one month after pIpC) mice. Bar graphs show relative expression levels for each fraction. Error bars: standard deviation.
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Finally, to test directly whether Lrf-mediated Dll4 repression in
erythroblasts is necessary for HSC maintenance, we established
Zbtb7aFlox/FloxErGFPCre mice in which the GFP/Cre fusion gene
is driven by the endogenous EpoR promoter,12 limiting Lrf
inactivation to erythroblasts. GFPcre was expressed in erythroid
lineage cells largely after the preCFU-E stage (Figure 7A, supple-
mental Figure 7A). As expected, Dll4 was significantly up-
regulated in TER119CD71 erythroblasts, whereas its expression
was not detected in nonerythroid cells (Figure 7B-C). Dll4
up-regulation occurred at the transcriptional level as observed in
Zbtb7aFlox/FloxMx1 Cre mice (supplemental Figure 7B). Reduction
in the number of Lrf transcripts and up-regulation of Bim, an Lrf
target gene in erythroblasts,21 were also confirmed by qRT-PCR
(supplemental Figure 7B). Strikingly, Zbtb7aFlox/FloxErGFPCre
mice phenocopied Zbtb7aFlox/FloxMx1 Cre mice, except the ane-
mia phenotype was milder. Aberrant DP T-cell development
with a concomitant block in B-cell development was evident in
the BM of Zbtb7aFlox/FloxErGFPCre mice (Figure 7D-E).
Moreover, absolute numbers of LT-HSCs and CLPs were significantly
reduced in Zbtb7aFlox/FloxErGFPCre mice (Figure 7F-G).
Discussion
In this study, we identified a novel mechanism that prevents
LT-HSCs from premature lymphoid differentiation in the BM. Lrf
deletion promoted up-regulation of Dll4 in erythroblasts, sensitiz-
ing LT-HSCs to T-cell instructive signals via Notch1 (Figure 7H).
Our findings are significant as they uncover previously unknown
cross-talk between HSC and erythroblasts and shed new light on
regulatory mechanisms regulating the balance between HSC self-
renewal and differentiation.
To determine the precise HSC/progenitor stage at which Lrf
antagonizes the Notch pathway, we performed multi-color FACS
analysis using a series of stem cell and lineage markers. Numbers of
LT-HSCs, Flt3 lymphoid biased multi-potential progenitors (LMPPs)
and CLPs were severely reduced in Lrf knockout mice. Complete
deletion of the Lrf gene in the HSC/progenitor compartment was
achieved 1 week after the first pIpC injection, and LT-HSC numbers
were reduced in Zbtb7aFlox/FloxMx1-Cre as early as 2 weeks after the
first pIpC injection (not shown). Although we previously showed that
numbers of LSKs and CLPs (defined as LinSca1c-KitIL7R
without Flt3 and Vcam-1 markers) were intact in Lrf knockout mice,8
most of the cells in these populations were T-cell precursors (eg,
Flt3CD150Vcam1CD48highCD25/ [Figure 1A arrowhead] and
Flt3IL7RSca-1c-KitCD25 [Figure 1A asterisk]). In fact, most
of these T-cell precursors were positive for Notch3 (supplemental Figure
2), whose expression is normally limited to CD4/8 double-negative
T cells in the thymus. Loss of HSCs in Lrf knockout mice was also
confirmed by side population assay and gene expression microarray
analysis.
When Lrf knockout mice were injected with 5-FU, LT-HSC
numbers did not recover to pretreatment levels; instead DP T cells
developed in the BM, suggesting that 5-FU–resistant dormant
HSCs differentiate toward the T-cell lineage rather than self-
renewing in response to the myeloablative stress. In agreement,
sequential 5-FU treatment killed Lrf knockout mice much earlier
than control mice because of lack of a sufficient HSC pool and
Figure 6. Dll4 blockade rescues aberrant HSC/lymphoid development in Lrf knockout mice in vivo. (A) Treatment schedule: 9 dosages of anti-Dll4 antibody were
administered intraperitoneally over 4 weeks. Mice were treated with pIpC (250 g/mouse) on days 1, 4, and 7. (B) Hematopoietic development in the BM was analyzed on day
28. Representative FACS profiles for each group are shown. (C) Dot graph shows proportions of DP T (top) and pre-B cell compartments (bottom) in BM. Horizontal black bars: average
value; error bars: standard deviation. (D) Dot graph shows numbers of LT-HSCs per 2 legs on day 28. Horizontal black bars: average value; error bars: standard deviation.
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Figure 7. Erythroid-specific deletion of the Lrf gene promotes aberrant lymphoid differentiation and HSC depletion. (A) Expression of the GFPCre fusion protein is
limited to erythroid lineage cells. Representative FACS profile of BM cells from control and ErGFPCre mice are shown. (B) Dll4 is up-regulated in erythroblasts of
Zbtb7aFlox/FloxErGFPCre mice. Representative FACS profiles of BM (top) and spleen (bottom) cells are shown. (C) Graph shows MFI scores of Dll4 staining in erythroid
(Ter119CD71) and nonerythroid (Ter119CD71) cells of control (white), Zbtb7aFlox/ErGFPCre (gray), and Zbtb7aFlox/FloxErGFPCre (black) mice. Error bars: standard
deviation. (D) Hematopoietic development in the BM was analyzed in 1-month-old mice. Representative FACS profiles for each group are shown. (E) Dot graph shows
proportions of DP T and pre-B cell compartments in BM. Horizontal black bars: average value. Error bars: standard deviation. (F) Representative HSC/progenitor FACS profiles
of control (Zbtb7aFlox/Flox) and erythroid-specific Lrf conditional knockout mice (Zbtb7aFlox/FloxErGFPCre). Experiments were performed as described in Figure 1A. Aberrant
T-cell progenitors within the Lin fraction are indicated by arrowheads. (G) Dot graphs of absolute counts (per 2 legs) of LT-HSCs and CLPs. Horizontal black bars: average
value. Error bars: standard deviation. (H) Notch proteins are expressed in the most primitive CD34 LT-HSCs. No or weak Notch1/Dll4-mediated signals are transmitted to
CD34 LT-HSCs under physiologic conditions and no premature T-cell differentiation occurs in the BM (left). In Lrf knockout mice, Dll4 is up-regulated (or de-repressed) in
erythroblasts. When CD34 LT-HSCs expressing high levels of Notch are stimulated by the high affinity Notch ligand Dll4, they receive T-instructive signals and differentiate
into T cells in the BM, resulting in HSC depletion.
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subsequent BM failure (Figure 4E). Importantly, this defect was
Notch1-dependent, because Notch1 loss rescued HSC defects seen
in Lrf knockout mice (Figure 4E). Thus, aberrant Notch signaling
accounts for quantitative and qualitative defects in HSC function
under stress conditions. Although Lrf deficiency impedes HSC
function under myeloablative conditions, Lrf-deficient HSCs sup-
ported myeloid reconstitution in a BM transplantation assay
(Figure 2D). Furthermore, Lrf-deficient HSCs gave rise to both
myeloid and erythroid lineage cells for a long period under
nonstress conditions (Figure 2E), suggesting that Lrf is necessary
for maintenance of a subset of LT-HSCs, which are dispensable for
erythroid and myeloid development under nonstress conditions.
Because CD34 LT-HSCs expressing high levels of Notch are particu-
larly sensitive to Lrf deletion and, without that population (as in the case
of Lrf knockout) both T and B-lymphoid development is perturbed, it is
tempting to speculate that CD34 LT-HSCs expressing high levels of
Notch are more “lymphoid-primed” (Figure 7H).
It is unclear whether Notch indeed functions in CD34 LT-HSCs
under physiologic conditions rather than being presented on
LT-HSCs as a “primed” status for differentiation. Notch function in
adult HSCs has been highly debated. Overexpression of ICN27 or
treatment of cells with Notch ligands resulted in increased HSC
number and reconstitution ability in vitro and in vivo, while
suppressing HSC/progenitor differentiation.28,29 However, data
from Chiang and colleagues suggests that persistent Notch signal-
ing in murine HSCs promotes T-cell differentiation at the expense
of LT-HSC self-renewal,30 results that are consistent with our
findings. Notch2, but not Notch1, enhances MPP and HSC
repopulation after 5-FU challenge by delaying myeloid differentia-
tion.31 Moreover, culturing human cord blood CD34 progenitor
cells in the presence of fibronectin fragments and immobilized
Dll1 ligand significantly reduces the time of myeloid engraft-
ment in patients undergoing myeloablative therapy.32 These data
support the idea that Notch positively regulates short-term
HSC/progenitor function after myeloablative treatment. However,
reports of the role for Notch in adult HSCs under physiologic
conditions are more contradictory. Although Duncan et al demon-
strated that canonical (RBPj/CSL-dependent) Notch pathways
were essential for HSC self-renewal via blocking HSC/progenitor
differentiation,33 loss-of-function studies of Notch signaling com-
ponents in mice indicate that the canonical Notch pathway is
dispensable for adult HSC function.10,34-36 Our study supports the
idea that Notch1 is dispensable for HSC function under stress
conditions as reported.31,35,37 Notch1 deletion rescued LT-HSCs
numbers in Lrf knockout mice under both nonstress and stress
conditions (Figure 4C-D) and prolonged survival of Lrf knock-
out mice after sequential 5-FU treatment (Figure 4E). Furthermore,
Notch1 knockout mice were protected from stress caused by sequential
5-FU treatment (Figure 4E). Although we do not exclude the possibility
that Notch2 functions in Lrf-deficient HSCs, our genetic data clearly
indicate that Notch1-mediated signals are the primary cause of exces-
sive T-cell differentiation and HSC depletion in Lrf conditional knock-
out mice.
The function of Notch ligands in the BM microenvironment is
not fully understood. Notch ligands are probably present at a
functional level in the BM niche, as Notch-mediated signals are
necessary for development of niche components, such as osteo-
blasts38 and endothelial cells.39 Jagged-1 protein is reportedly
expressed in primary cultured mouse FL and BM stromal cells.40
Osteoblast-specific activation of the parathyroid hormone receptor
in mice leads to expansion of Jagged-1 expressing osteoblastic
cells, which support propagation of LSK cells through Notch1/
Jagged-1 signals.41 Furthermore, Butler et al recently reported that
both Jagged-1 and 2 are expressed in sinusoidal endothelium cells
(SECs) in the BM and that Jagged-mediated Notch signals from
SECs promote proliferation and prevent exhaustion of LT-HSCs
after myeloablation.42 However, inactivation of Jagged-1 in mouse
BM HSC/progenitors or BM stromal cells (in which Cre is driven
by the Mx1 promoter) had no effect on HSC maintenance.35
Dll4 is constitutively expressed on thymic epithelial cells
(TECs)43 and endothelial cells.44 Dll4 also has a critical function in
T-cell development23,24 and vascular morphogenesis,39 where it
regulates specification of endothelial cells into tip and stalk cells
during angiogenic sprouting. However, the role of Dll4 on BM
HSC function is not understood. Here, for the first time, we show
expression patterns of Dll4 in BM using anti-Dll4 antibody.26 As
expected, Dll4 was expressed on mature vessel endothelium and at
a lower level on immature endothelium but not in hematopoietic
cells (Figure 5A, supplemental Figure 4). FACS analysis confirmed
lack of Dll4 expression in hematopoietic cells in the BM, thymus,
and spleen (Figure 5B-D and not shown). Unexpectedly, Dll4, but
not Dll1, was significantly up-regulated in Lrf-deficient erythro-
blasts. The up-regulation was cell-type and differentiation-stage
specific (Figures 5B-C and 7B) and occurred at the transcriptional
level (Figure 5D). It was not a consequence of stress hematopoiesis
or PHZ-induced stress erythropoiesis, as no Dll4 was seen in
erythroblasts of 5-FU or PHZ-treated WT mice (supplemental
Figure 5B and not shown). Furthermore, high Dll4 expression in
erythroblasts remained evident in Lrf/Notch1 double-knockout
mice, suggesting that Dll4 expression is enhanced in Lrf-deficient
erythroblasts in a Notch1-independent fashion. Although Dll4
antibody could also block Dll4 in nonerythroid cells, considering
that Dll4 up-regulation is limited to erythroid cells (Figure 5), it is
fairly reasonable to expect that anti-Dll4 antibody blocks Dll4
protein in erythroblasts, leading to nearly normal lymphoid devel-
opment in Lrf knockout mice. Because (1) Dll4 blockade rescued
LT-HSC numbers and aberrant lymphoid lineage fate (Figure 6),
and (2) erythroid-specific Lrf deletion led to HSC depletion and
aberrant lymphoid differentiation (Figure 7G), we conclude that
Dll4 repression by Lrf in erythroblasts is essential for HSC
maintenance in the BM (Figure 7H).
Vascular endothelial growth factor (VEGF) up-regulates Dll4
transcription in endothelial cells, at least in part, via Fox transcrip-
tion factors.45,46 However, how Dll4 is regulated in other cell types
is entirely unclear. Levels of Dll4 expression must be tightly
regulated in hematopoietic cells as well as BM microenvironment,
as its aberrant expression could activate Notch-expressing cells,
causing disease states such as leukemia. Our study indicates that
Notch1/Dll4-mediated signals must be turned off or maintained at
low levels in the BM under physiologic conditions to prevent HSCs
from differentiating prematurely into T cells in the BM, as seen in
Lrf knockout mice. Interestingly, unlike other constitutively active
Notch mouse models,47-49 Zbtb7aFlox/FloxMx1-Cre mice never
develop T-cell leukemia, even after a long period of time,
indicating enhanced Notch1/Dll4 signals that Lrf-deficient HSCs
receive from erythroblasts are not sufficient for leukemic transfor-
mation but rather are similar to signals that thymus-homing
progenitors receive from TECs. Although the precise molecular
mechanisms by which LRF represses Dll4 in erythroblasts remain
elusive, LRF is one of the few factors known to negatively regulate
Dll4 expression. LRF may cooperate with an erythroid-specific
factor(s) to repress Dll4 transcription, given the ubiquitous expres-
sion of LRF in hematopoietic cells.8,21,50
In conclusion, we have identified LRF as a new key factor for
adult HSC maintenance. Lrf represses Dll4 in erythroblasts,
preventing LT-HSCs from premature differentiation toward T cells.
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